|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Amyloid Beta (1-42) ELISA Assay | Angiotensinogen Total ELISA Assay | Bordetella pertussis IgM ELISA | Gd-IgA1 (Galactose-deficient IgA1) ELISA | Insulin IRMA Assay |
| Citations | | | | | |
| Catalog Number | 27711 | 27412 | IB79851 | 27600 | KIP1251 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Solid phase sandwich ELISA for the determination of human Aß(1-42) in cerebrospinal fluid, cell culture media or the extract from brain tissue. For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of human Angiotensinogen ELISA in serum, EDTA-plasma, urine, or cell culture media. For research use only, not for use in diagnostic procedures. | The Bordetella pertussis IgM ELISA is intended for the determination of IgM class antibodies against Bordetella pertussis in human serum or plasma (citrate, heparin). For research use only - not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the Solid phase sandwich ELISA for the determination of Gd-IgA1 (Galactose-deficient IgA1) in human serum, EDTA-plasma, and urine. For research use only, not for use in diagnostic procedures.
Galactose-deficient IgA1 (Gd-IgA1) has attracted a lot of attention as a critical effector molecule in the pathogenesis and progression of IgA nephropathy (IgAN) in recent studies. It has been suggested that several O-link glycans-modified regions exist in the heavy chain hinge region of human IgA1 molecule and Gd-IgA1 circulates in the bloodstream of test samples with the pathological condition of IgAN.... Read More | Immunoradiometric assay (RIA) for the quantitative determination of human Insulin (INS) in serum. FDA exempt, can be used for in-vitro diagnostics. |
| Detection Target | Anti-Infliximab (Remicade®, Remsima®, and Inflectra®) (ATI) | Anti-Bevacizumab (Avastin®) | Serotonin | Metanephrine / Normetanephrine | Leptin |
| Sample Type | Serum and plasma. | Serum and plasma. | Multiple | Urine | Serum, Blood Plasma, Urine, Saliva |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Radio Immuno Assay (RIA) |
| Detection Range | 12.5 to 800 pg/mL | 0.31 to 20.00 ng/mL | A cut-off control is used for the interpretation of results. | 1.56 to 100.0 ng/mL | 5.7 to 440 µIU/mL |
| Sensitivity | 1 ng/mL | 40 ng/mL | 0.005 ng/mL x Correction Factor based upon volume of sample used. | Metanephrine: 13 ng/mL; Normetanephrine: 23 ng/mL. | 1.0 ng/mL |
| Assay Time | Overnight + 1 hr 30 mins (incubation) | 2 hrs (incubation) | 1 hr 45 mins (incubation) | 2 hours (incubation) | 2 hrs (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |